The CICERO (Collaboration In COPD ExaceRbatiOns) Clinical Research Collaboration

Abstract

Marcus Tullius Cicero was a famous Roman (b. 106 BC) with enterprise in politics, philosophy and oration. Cicero was recognised as a forefather of modernising Latin and Latin prose and for providing the building blocks of many European languages. His most famous of works De Officis was the second book to be printed in Europe after the Gutenberg Bible (c1455), establishing his relevance to both the European and global community. One of Cicero's most famous quotes is “Quousque tandem abutere, patientia nostra” said to Lucius Sergius Catilina (b. 108 BC) upon exposure of the plot to overthrow Rome (c. 63 BC). “ When, do you mean to stop abusing our patience”, the translation of Cicero's most famous quote, is highly relevant when pointing to the necessity and urgency of this new Clinical Research Collaboration (CRC). CICERO is a new Clinical Research Collaboration (CRC), studying severe exacerbations of COPD <http://bit.ly/30K2BDi> This article was written on behalf of the CICERO Clinical Research Collaboration members. Founding members: Pierre Regis-Burgel, France; Marco Contoli, Italy; Lowie Van Fleteren, Sweden; Arturo Huerta Garcia, Spain; Frits Franssen, The Netherlands; Neil Greening, UK; Timm Greulich, Germany; Jennifer Quint, UK; Henrik Watz, Germany. Young investigators: Sanjay Ramakrishnan, Australia; Iwein Gyselinck, Belgium; Andreas Halner, UK; Kristina Vermeersch, Belgium. Advisory panel: Richard Albert, USA; Christine Jenkins, Australia; Claus Vogelmeier, Germany. Patient and European Lung Foundation representatives: Philip Collis; Hilma Bolsman; Courtney Coleman. Supporting industry partners: AstraZeneca; GlaxoSmithKline; Roche.